RecruitingNCT07107022

Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).

i-RISE: International Acute Ischemic Stroke Study With the Penumbra System®


Sponsor

Penumbra Inc.

Enrollment

200 participants

Start Date

Nov 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a patient population with acute ischemic stroke (AIS)


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Penumbra System ® for people with acute ischemic stroke ais. The study is currently recruiting participants at 10 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPenumbra System ®

Neurovacular Mechanical Thrombectomy with the Penumbra System®


Locations(10)

Sir Charles Gairdner Hospital

Nedlands, Western Australia, Australia

CHU de Bordeaux - Hôpital Pellegrin

Bordeaux, France

CHU de Brest - Hôpital de la Cavale Blanche

Brest, France

Hôpital Pierre-Paul Riquet

Toulouse, France

TUM Klinikum rechts der Isar

München, Bavaria, Germany

Knappschaft Kliniken Vest Recklinghausen

Recklinghausen, Westphalia, Germany

Universitätsklinikum Augsburg

Augsburg, Germany

Universitätsklinikum Schleswig-Holstein (UKSH) Lübeck

Lübeck, Germany

Universitätsspital Basel

Basel, Basel-Landschaft, Switzerland

Inselspital Universitätsklinik für Neurologie

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07107022


Related Trials